Navigation Links
PRI Condemns PEPFAR Amendments
Date:2/6/2008

FRONT ROYAL, Va., Feb. 6 /PRNewswire-USNewswire/ --- Population Research Institute has joined other pro-life groups in condemning amendments to the President's Emergency Plan for AIDS Relief (PEPFAR).

PEPFAR is up for reauthorization on Thursday, February 14, 2008, in the House Foreign Affairs Committee. According to PRI's president Steven Mosher, the preliminary drafts have been compromised by amendments that put the money directly in the hands of known population controllers.

"It would be better if President Bush had never proposed PEPFAR, than to have 50 billion dollars hijacked by abortion-promoting, chastity-mocking, anti-people groups like IPPF, UNFPA, and the Chinese government," said Mosher. "If the amendments promoted by the Democrat majority are passed, a veto will be the President's only option."

These amendments include "family planning" language that does not exclude abortion, lifting important abortion restrictions imposed by the Mexico City Policy, a removal of the anti-prostitution pledge, and a full integration of family planning services with HIV aid services.

PRI urges pro-lifers everywhere to contact the members of the House Foreign Affairs Committee and encourage them to vote against this bill. Information about this committee can be found at http://www.foreignaffairs.house.gov.

The Population Research Institute (PRI) was founded in 1989 by Fr. Paul Marx, OSB, PhD and is dedicated to: (1) ending human rights abuses committed in the name of "family planning," (2) opposing outdated social and economic paradigms premised on the myth of overpopulation, (3) informing the public about the social and economic benefits of moderate population growth, and (4) promoting pro-natal and pro-family attitudes and policies worldwide.


'/>"/>
SOURCE Population Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Catholic Health Association Condemns Denial of Health Insurance for Children
2. Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
3. China Sky One Medical Completes Previously Announced Amendments to Form 10QSB for the Second and Third Quarters of 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
Breaking Medicine Technology: